Table 1

 Age, sex and risk factors for acute renal failure (ARF)

NoAge (y)SexAminoglycosidePrior/concurrent*CeftazidimeNebulised antibiotic†Other nephrotoxic drugOther risk factor
c, concurrent; e, ever; IV, intravenous; CFRD, cystic fibrosis-related diabetes; MRSA, methicillin-resistant Staphylococcusaureus;
*Timing of aminoglycoside in relation to ARF: concurrent, at the time ARF diagnosed; prior, within the week prior to ARF.
†Patients receiving nebulised tobramycin had intravenous solution in nebulised form.
10.4MGentamicinPriorYesColistin (e)Diarrhoea and vomiting
221.1FGentamicinConcurrentYesColistin (e)Diclofenac (c)
36.9MGentamicin then tobramycinPrior/concurrentYesNone
45.0MGentamicinConcurrentYesNoneFever
55.7MGentamicinConcurrentNoGentamicin (c)Neonatal renal cortical necrosis
611.9FTobramycinConcurrentNoColistin (c)Ibuprofen (c)Fever
74.4MGentamicinPriorYesColistin (e)
818.6FNoneColistin (c)‘Flu-like illness following oral rifampicin and ciprofloxacin. CFRD
912.3FGentamicinPriorYesTobramycin (c)Ciclosporin (e)
1017.0FTobramycinConcurrentNoColistin (c)Toxic shock. Clostridium difficile toxin in stool
1131.8FGentamicinPriorYesGentamicin (e)CFRD and diabetic nephropathy
129.6MGentamicinConcurrentYesColistin (c)Ciclosporin (c)CFRD
133.6MGentamicinConcurrentYesColistin (c)Diarrhoea and vomiting
147.4MGentamicinPriorYesColistin (c)Previous pseudo Barter’s syndrome
159.8MTobramycinConcurrentNoGentamicin (e)Indomethacin (c)
1615.0MTobramycinConcurrentNoTobramycin (c)CFRD, ventilated, MRSA septicaemia
1715.9FTobramycinConcurrentNoColistin (c)Colistin (IV)CFRD
189.8MGentamicinConcurrentNoNoneNaproxen (e) and diclofenac (e)Constipation, osmotic laxatives
193.6MGentamicinConcurrentYesColistin (c)Gastro-oesophageal reflux, vomiting
2012.1FNoneNoneNaproxen (c)RhF +ve arthritis
2117.3FNoneColistin (e)CFRD
228.0FGentamicinPriorYesColistin (c)
238.0FGentamicinConcurrentYesColistin (c)
249.0FGentamicinPriorYesColistin (c)